Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma.

Sandrine FaivreArmando SantoroRobin K KelleyEd GaneCharlotte E CostentinIvelina GueorguievaClaire SmithAnn CleverlyMichael M LahnEric RaymondKarim A BenhadjiGianluigi Giannelli

Published in: Liver international : official journal of the International Association for the Study of the Liver (2019)

NCT01246986 at ClinicalTrials.gov.

Keyphrases

transforming growth factor
epithelial mesenchymal transition
binding protein
signaling pathway